| Dr Leigh S Lopresti, MD | |
|
130 Fisher Rd, Berlin, VT 05602-9516 | |
| (802) 371-4100 | |
| Not Available |
| Full Name | Dr Leigh S Lopresti |
|---|---|
| Gender | Male |
| Speciality | Family Practice |
| Experience | 41 Years |
| Location | 130 Fisher Rd, Berlin, Vermont |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1619928462 | NPI | - | NPPES |
| 0005973 | Medicaid | VT |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | 56005 (Massachusetts) | Secondary |
| 207Q00000X | Family Medicine | 0420007260 (Vermont) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Central Vermont Home Health & Hospice | Barre, VT | Home health agency |
| Bayada Hospice | Norwich, VT | Hospice |
| Caledonia Home Health Care | Saint johnsbury, VT | Hospice |
| Central Vermont Medical Center | Barre, VT | Hospital |
| Northeastern Vermont Regional Hospital | Saint johnsbury, VT | Hospital |
| Berlin Health & Rehab Ctr | Barre, VT | Nursing home |
| Bel Aire Center | Newport, VT | Nursing home |
| Springfield Health & Rehab | Springfield, VT | Nursing home |
| St Johnsbury Health & Rehab | Saint johnsbury, VT | Nursing home |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Central Vermont Medical Center Inc | 9335138817 | 204 |
News Archive
The combination of Biothera's experimental drug Imprime PGG® and Erbitux® (cetuximab) doubled the historical overall response rate and the time to progression of second- and third-line metastatic colorectal cancer patients treated with Erbitux monotherapy. The data was released last weekend at the 13th World Congress on Gastrointestinal Cancer at the European Society for Medical Oncology (ESMO).
International Stem Cell Corporation, announced today the achievement of a major milestone in its efforts to establish a bank of immune-matched parthenogenetic stem cells in the United States by receiving the statutory approvals required to move forward with the next phase of its stem cell banking program.
Stronger alcohol policies, including those targeting both excessive drinking and driving while impaired by alcohol, reduce the likelihood of alcohol-related motor vehicle crash deaths, according to a new study from Boston Medical Center and Boston University.
When our plasma cells start producing a single cancer-causing protein rather than an array of antibody-like proteins to protect us, it's one of two arms of the Y-shaped protein that's likely to blame.
› Verified 5 days ago
| Entity Name | Gifford Medical Center Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1942329446 PECOS PAC ID: 4880683663 Enrollment ID: O20040507000460 |
News Archive
The combination of Biothera's experimental drug Imprime PGG® and Erbitux® (cetuximab) doubled the historical overall response rate and the time to progression of second- and third-line metastatic colorectal cancer patients treated with Erbitux monotherapy. The data was released last weekend at the 13th World Congress on Gastrointestinal Cancer at the European Society for Medical Oncology (ESMO).
International Stem Cell Corporation, announced today the achievement of a major milestone in its efforts to establish a bank of immune-matched parthenogenetic stem cells in the United States by receiving the statutory approvals required to move forward with the next phase of its stem cell banking program.
Stronger alcohol policies, including those targeting both excessive drinking and driving while impaired by alcohol, reduce the likelihood of alcohol-related motor vehicle crash deaths, according to a new study from Boston Medical Center and Boston University.
When our plasma cells start producing a single cancer-causing protein rather than an array of antibody-like proteins to protect us, it's one of two arms of the Y-shaped protein that's likely to blame.
› Verified 5 days ago
| Entity Name | Genesis Eldercare Physician Services Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1477576304 PECOS PAC ID: 9830002534 Enrollment ID: O20040722000327 |
News Archive
The combination of Biothera's experimental drug Imprime PGG® and Erbitux® (cetuximab) doubled the historical overall response rate and the time to progression of second- and third-line metastatic colorectal cancer patients treated with Erbitux monotherapy. The data was released last weekend at the 13th World Congress on Gastrointestinal Cancer at the European Society for Medical Oncology (ESMO).
International Stem Cell Corporation, announced today the achievement of a major milestone in its efforts to establish a bank of immune-matched parthenogenetic stem cells in the United States by receiving the statutory approvals required to move forward with the next phase of its stem cell banking program.
Stronger alcohol policies, including those targeting both excessive drinking and driving while impaired by alcohol, reduce the likelihood of alcohol-related motor vehicle crash deaths, according to a new study from Boston Medical Center and Boston University.
When our plasma cells start producing a single cancer-causing protein rather than an array of antibody-like proteins to protect us, it's one of two arms of the Y-shaped protein that's likely to blame.
› Verified 5 days ago
| Entity Name | Central Vermont Medical Center Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1023028784 PECOS PAC ID: 9335138817 Enrollment ID: O20051220000393 |
News Archive
The combination of Biothera's experimental drug Imprime PGG® and Erbitux® (cetuximab) doubled the historical overall response rate and the time to progression of second- and third-line metastatic colorectal cancer patients treated with Erbitux monotherapy. The data was released last weekend at the 13th World Congress on Gastrointestinal Cancer at the European Society for Medical Oncology (ESMO).
International Stem Cell Corporation, announced today the achievement of a major milestone in its efforts to establish a bank of immune-matched parthenogenetic stem cells in the United States by receiving the statutory approvals required to move forward with the next phase of its stem cell banking program.
Stronger alcohol policies, including those targeting both excessive drinking and driving while impaired by alcohol, reduce the likelihood of alcohol-related motor vehicle crash deaths, according to a new study from Boston Medical Center and Boston University.
When our plasma cells start producing a single cancer-causing protein rather than an array of antibody-like proteins to protect us, it's one of two arms of the Y-shaped protein that's likely to blame.
› Verified 5 days ago
| Entity Name | Battenkill Valley Health Center Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1033530696 PECOS PAC ID: 2769612548 Enrollment ID: O20140827001201 |
News Archive
The combination of Biothera's experimental drug Imprime PGG® and Erbitux® (cetuximab) doubled the historical overall response rate and the time to progression of second- and third-line metastatic colorectal cancer patients treated with Erbitux monotherapy. The data was released last weekend at the 13th World Congress on Gastrointestinal Cancer at the European Society for Medical Oncology (ESMO).
International Stem Cell Corporation, announced today the achievement of a major milestone in its efforts to establish a bank of immune-matched parthenogenetic stem cells in the United States by receiving the statutory approvals required to move forward with the next phase of its stem cell banking program.
Stronger alcohol policies, including those targeting both excessive drinking and driving while impaired by alcohol, reduce the likelihood of alcohol-related motor vehicle crash deaths, according to a new study from Boston Medical Center and Boston University.
When our plasma cells start producing a single cancer-causing protein rather than an array of antibody-like proteins to protect us, it's one of two arms of the Y-shaped protein that's likely to blame.
› Verified 5 days ago
| Entity Name | Gps Physician Group, Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1881109452 PECOS PAC ID: 9739447400 Enrollment ID: O20180503001779 |
News Archive
The combination of Biothera's experimental drug Imprime PGG® and Erbitux® (cetuximab) doubled the historical overall response rate and the time to progression of second- and third-line metastatic colorectal cancer patients treated with Erbitux monotherapy. The data was released last weekend at the 13th World Congress on Gastrointestinal Cancer at the European Society for Medical Oncology (ESMO).
International Stem Cell Corporation, announced today the achievement of a major milestone in its efforts to establish a bank of immune-matched parthenogenetic stem cells in the United States by receiving the statutory approvals required to move forward with the next phase of its stem cell banking program.
Stronger alcohol policies, including those targeting both excessive drinking and driving while impaired by alcohol, reduce the likelihood of alcohol-related motor vehicle crash deaths, according to a new study from Boston Medical Center and Boston University.
When our plasma cells start producing a single cancer-causing protein rather than an array of antibody-like proteins to protect us, it's one of two arms of the Y-shaped protein that's likely to blame.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Leigh S Lopresti, MD 130 Fisher Rd, Berlin, VT 05602-9516 Ph: (802) 371-4100 | Dr Leigh S Lopresti, MD 130 Fisher Rd, Berlin, VT 05602-9516 Ph: (802) 371-4100 |
News Archive
The combination of Biothera's experimental drug Imprime PGG® and Erbitux® (cetuximab) doubled the historical overall response rate and the time to progression of second- and third-line metastatic colorectal cancer patients treated with Erbitux monotherapy. The data was released last weekend at the 13th World Congress on Gastrointestinal Cancer at the European Society for Medical Oncology (ESMO).
International Stem Cell Corporation, announced today the achievement of a major milestone in its efforts to establish a bank of immune-matched parthenogenetic stem cells in the United States by receiving the statutory approvals required to move forward with the next phase of its stem cell banking program.
Stronger alcohol policies, including those targeting both excessive drinking and driving while impaired by alcohol, reduce the likelihood of alcohol-related motor vehicle crash deaths, according to a new study from Boston Medical Center and Boston University.
When our plasma cells start producing a single cancer-causing protein rather than an array of antibody-like proteins to protect us, it's one of two arms of the Y-shaped protein that's likely to blame.
› Verified 5 days ago
Dr. Jennifer Brennan Bamford, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 130 Fisher Rd., Uvm Medical Center - Fm/berlin, Berlin, VT 05602 Phone: 802-847-7000 Fax: 802-847-7103 | |
Dr. Benjamin Arthur Flinn, MD Family Medicine Medicare: Medicare Enrolled Practice Location: 130 Fisher Rd Unit 1, Berlin, VT 05602 Phone: 802-225-7000 | |
Thomas James Curchin, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 246 Granger Rd, Suite 2, Berlin, VT 05602 Phone: 802-225-5810 Fax: 802-371-4821 | |
Dr. Stuart E Williams, M.D. Family Medicine Medicare: May Accept Medicare Assignments Practice Location: 130 Fisher Rd, Berlin, VT 05602 Phone: 802-225-7000 | |
Dr. Jose Lopez, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 130 Fisher Rd Ste 3-1, Berlin, VT 05602 Phone: 802-225-9000 | |
Dr. Lise S Kowalski, M.D. Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 130 Fisher Rd, Suite 3-1, Berlin, VT 05602 Phone: 802-225-7000 | |
Arturo Guajardo, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 130 Fisher Rd Unit 1, Berlin, VT 05602 Phone: 802-225-7103 |